An original stem cell study provides insight into Klinefelter syndrome.

Published Date: 05 Apr 2023

Scientists have conducted a first-of-its-kind study in a collaboration between King Abdullah University of Science and Technology (KAUST), King Abdulaziz University, Jeddah (KAU), and King Abdulaziz University Hospital, Jeddah (KAUH).

Read Full News

Latest News

10-Hour Eating Window Boosts Weight Loss in Obesity

10-hour time-restricted eating promotes greater weight loss and improved body composition in adults with obesity and without diabetes than standard dietary counseling alone.

US Health Department Proposes Testosterone Therapy Label Updates

The U.S. health department said on Thursday it was seeking updates to labels for testosterone replacement therapies after reviewing new clinical data ⁠and other...

The HPV Vaccine at 20: Progress Made, Challenges Ahead

Evidence supports HPV vaccination as a powerful cancer prevention tool, but improving its uptake remains critical for achieving long-term public health goals.

AGA Updates POWER Guide for Obesity, Weight Management

Updated guidance from the American Gastroenterological Association aims to help clinicians navigate the growing number of obesity and weight-management treatment options.

Breast Cancer Patients Taking GLP-1s Had Better Survival

The findings from a large observational study underscore the need for randomized clinical trials to assess the relationship between GLP-1 use and outcomes in patients with cancer.

MRI Predicts Survival Better Than Pathology in Rectal Cancer

MRI provides a more reliable preoperative prediction of survival and recurrence in patients with rectal tumour than traditional histopathology.

Todays Updates

Dostarlimab Boosts Long-Term Survival in Endometrial Cancer

At 4 years, dostarlimab plus chemotherapy reduced the risk for death by two thirds among patients with dMMR/MSI-H advanced endometrial cancer, pointing to curative potential, experts say.

Todays Updates

Dostarlimab Boosts Long-Term Survival in Endometrial Cancer

At 4 years, dostarlimab plus chemotherapy reduced the risk for death by two thirds among patients with dMMR/MSI-H advanced endometrial cancer, pointing to curative potential, experts say.

Latest News

10-hour time-restricted eating promotes greater weight loss and improved body composition in adults with obesity and without diabetes than standard dietary counseling alone.

The U.S. health department said on Thursday it was seeking updates to labels for testosterone replacement therapies after reviewing new clinical data ⁠and other...

Evidence supports HPV vaccination as a powerful cancer prevention tool, but improving its uptake remains critical for achieving long-term public health goals.

Updated guidance from the American Gastroenterological Association aims to help clinicians navigate the growing number of obesity and weight-management treatment options.

The findings from a large observational study underscore the need for randomized clinical trials to assess the relationship between GLP-1 use and outcomes in patients with cancer.

MRI provides a more reliable preoperative prediction of survival and recurrence in patients with rectal tumour than traditional histopathology.

News All Time

Male Fertility Not Harmed by GLP-1s and Maybe Helped

A systematic review finds no consistent adverse effects on the male hypothalamic-pituitary-gonadal axis and some evidence of fertility improvement with GLP-1 use.

Tirzepatide May Reverse Postbariatric Weight Regain

Tirzepatide treatment yields substantial weight loss and is well tolerated in patients with recurrent weight gain after bariatric procedures, a small real-world observational study finds.

Distinct Courses in Primary and Secondary Empty Sella

Patients with primary and secondary empty sella show distinct clinical and endocrine trajectories over a median follow-up of about 5 years.

Does Tirzepatide Activate Brown Fat?

Tirzepatide seems to activate brown adipose tissue, potentially modulating energy expenditure at the tissue level in premenopausal women with obesity.

Semaglutide Linked to Fewer Fractures

In contrast to concerns of lean mass loss with GLP-1 receptor agonists, a large population-based study found lower fracture rates with semaglutide than with other weight-loss medications.

Novel Monoclonal Antibody Shows Benefit in Cushing Disease

The anti-adrenocorticotropic hormone antibody asedebart normalized urinary free cortisol in 7 of 8 study participants.

GLP-1s Aren’t a Solo Act. They Need Comprehensive Planning

Lifestyle changes, tracking, and support should go hand-in-hand with weight loss drugs.

AI Eye Scan Cuts Unneeded Diabetes Macular Edema Referrals

An AI-based OCT system integrated into standard diabetic retinopathy screening pathways reduces unwarranted referrals for diabetic macular edema, a recent study shows.

Neumora Scraps Depression Drug Development After Repeated Trial Failures

Neumora Therapeutics will abandon the development of its experimental depression drug following the latest trial failures and ⁠said it would cut 35% of its workforce,...

Chronic Opioid Use Raises Risk for Endocrinopathies

Possible complications include adrenal insufficiency, hypogonadism, hyperprolactinemia, hospitalization, and mortality.

Teplizumab Approved for Pediatric Stage 3 Type 1 Diabetes

The drug was previously approved for stage 2 T1D.

Encaleret Shows Rapid Response in ADH1

The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.

Testosterone Prescribing Often Ignores Guidelines

Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.

Palopegteriparatide Benefits Sustained Beyond 3 Years

Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.

One in Four Teen Girls and Young Women at Risk for PMOS

Findings suggest young females should be assessed and, if at risk, monitored.

Novo Nordisk Flags Patient Data Breach From Some Clinical Trials in Cyberattack

Novo Nordisk said on Thursday it has identified a security incident in which certain information, including ⁠patient data from some clinical trials, was copied externally...